We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...
Biosciences presented data from the KINECT-HD study showcasing significant improvements in chorea across body regions with ...
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy” rating ...
M&T Bank Corp lifted its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 23.4% in the fourth ...
24/7 Wall St. on MSN9h
Billionaire Healthcare Investor Alex Denner’s Hedge Fund Has 75% of Its Assets in These 3 StocksIf you work in the biotech industry, you might know the name Alex Denner. If not, his name probably doesn’t ring a bell. ...
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the Stifel 2025 Virtual CNS Forum at 1:30 p.m. Eastern Time on Tuesday, March 18, 2025. Chief Executive Officer Kyle Gano and Chief ...
TD Cowen analyst Phil Nadeau maintained a Hold rating on Xoma (XOMA – Research Report) yesterday. The company’s shares closed yesterday at ...
SAN DIEGO, March 11, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the Stifel 2025 Virtual CNS Forum at 1:30 p.m. Eastern Time on Tuesday, March 18 ...
In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech ...
The round, which included more than a dozen investment firms, should give the startup enough cash to get late-stage data for ...
Ionis’ drug, called sapablursen, is currently being tested in a Phase 2 trial in people with polycythemia vera.
Researchers have conducted the first national survey on public awareness and perceptions of food, health, and Food is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback